In the December 5, 2014, Federal Register, FDA withdrew its approval of 23 new drug applications ("NDAs") and 68 ANDAs from multiple applicants. The holders of the applications notified the Agency in writing that the drug products were no longer marketed and requested the approval of the applications be withdrawn.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
